# Allowable Excess Volume and Labeled Vial Fill Size in Injectable Drug and Biological Products - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/allowable-excess-volume-and-labeled-vial-fill-size-in-injectable-drug-and-biological-products/23e78a60-a44a-4fe0-840f-72c23de18934

> FDA guidance document: Allowable Excess Volume and Labeled Vial Fill Size in Injectable Drug and Biological Products. Issue date: June 25, 2015. Get complete insights and analysis.

---

## Details

- Title: Allowable Excess Volume and Labeled Vial Fill Size in Injectable Drug and Biological Products
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2015-06-25
- Last Changed: 2020-05-06
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2014-D-0248">FDA-2014-D-0248</a>

## Related Documents

- [Analytical Procedures and Methods Validation for Drugs and Biologics](https://www.globalkeysolutions.net/guidances/guidance-document/analytical-procedures-and-methods-validation-for-drugs-and-biologics/b63babeb-6796-4e5d-a992-7830e31b2f5a)
- [General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/general-clinical-pharmacology-considerations-for-neonatal-studies-for-drugs-and-biological-products-guidance-for-industry/0c57731e-55bc-4962-a619-54444aa22335)
- [Patient Counseling Information Section of Labeling for Human Prescription Drug and Biological Products — Content and Format](https://www.globalkeysolutions.net/guidances/guidance-document/patient-counseling-information-section-of-labeling-for-human-prescription-drug-and-biological-products-content-and-format/91c267ae-e99d-4508-b31c-721b7da25d2b)